On October 9, US spot Bitcoin ETFs recorded $21.13 million in net inflows, led by BlackRock's iShares Bitcoin Trust (IBIT) which alone brought in $22.38 million. This inflow followed a large outflow of $244.1 million the previous day. Meanwhile, spot Ethereum ETFs continued their decline with $56.10 million in net outflows, marking the ninth consecutive day of withdrawals, with BlackRock's ETHA contributing significantly to the outflows. Despite recent volatility, since their launch in January 2024, spot Bitcoin ETFs have accumulated around $57.11 billion in net inflows, managing assets worth approximately $105.84 billion. The contrasting flows highlight selective investor interest, with Bitcoin ETFs gaining while Ethereum ETFs are trimmed, reflecting differing market sentiment towards these cryptocurrencies.
Bitcoin spot ETFs net inflows on October 9 provide context for cryptocurrency trends. For readers following digital assets, here is Pluang's market snapshot as of Oct 10, 2026 12:51 WIB: Of 50 priced major cryptocurrencies tradable on Pluang, 36 rose and 13 fell today. Notable performers include BAL (Balancer) at Rp16.297 with a 1-day change of +11.14%, DOT (Polkadot) at Rp22.765 with +9.38% and a Pluang order activity of 31% Sell / 69% Buy, and THETA (Theta Network) at Rp4.144 with +8.20% and a Pluang order activity of 0% Sell / 100% Buy.
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...
Northern Discovery Metals has finalized the acquisition of a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties. The project covers about 3,567 hectares near Houston, BC, in a region known for porphyry copper de...
Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...
Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...
